# Augtyro

NDC: 0003-4160
Generic name: repotrectinib
Labeler / Manufacturer: E.R. Squibb & Sons, L.L.C.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20241101

FDA application: NDA218213

## Active ingredients

- REPOTRECTINIB: 160 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0003-4160"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0003-4160
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fb526827-40ba-4462-94cf-179ae3b0cb8a